Atara Biotherapeutics (ATRA) Capital Expenditures Growth (1y) (2015 - 2024)
Atara Biotherapeutics (ATRA) Capital Expenditures Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 104.05% |
| Jun 30, 2024 | -77.84% |
| Dec 31, 2023 | -8,646.15% |
| Sep 30, 2023 | 389.69% |
| Jun 30, 2023 | 128.47% |
| Mar 31, 2023 | -92.55% |
| Dec 31, 2022 | -90.75% |
| Sep 30, 2022 | 95.96% |
| Jun 30, 2022 | -219.99% |
| Mar 31, 2022 | 18.57% |
| Dec 31, 2021 | -53.24% |
| Sep 30, 2021 | -577.14% |
| Jun 30, 2021 | -0.72% |
| Mar 31, 2021 | 64.82% |
| Dec 31, 2020 | -77.84% |
| Sep 30, 2020 | -80.26% |
| Jun 30, 2020 | 742.72% |
| Mar 31, 2020 | 67.46% |
| Dec 31, 2019 | 213.28% |
| Sep 30, 2019 | 330.59% |